scholarly journals Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong

2019 ◽  
Vol 145 (1) ◽  
pp. 267-273 ◽  
Author(s):  
Kelvin K.F. Tsoi ◽  
Jason M.W. Ho ◽  
Felix C.H. Chan ◽  
Joseph J.Y. Sung
2017 ◽  
Vol 5 (7) ◽  
pp. 1030-1036 ◽  
Author(s):  
Yusuke Takasaki ◽  
Naoyoshi Nagata ◽  
Koh Imbe ◽  
Yuya Hisada ◽  
Katsunori Sekine ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Ying-Cheng Chen ◽  
Yin-Yang Chen ◽  
Han Wei Yeh ◽  
Tung-Ying Yeh ◽  
Jing-Yang Huang ◽  
...  

This study evaluated the association between long-term low-dose aspirin use and decreased risk of pneumonia in patients with cardio-cerebra-vascular ischemic diseases (CCVDs). This retrospective cohort study used records from Taiwan's National Health Insurance Research Database of claims made between 1997 and 2013. After propensity score matching (PSM), patients who took a low dose of aspirin for more than 90 days within 1 year of diagnosis with CCVDs were identified as the exposure group (n = 15,784). A matched total of 15,784 individuals without aspirin use were selected for the non-aspirin group. The main outcome was the development of pneumonia after the index date. Multivariable Cox regression analysis and Kaplan–Meier survival analysis were performed to estimate the adjusted hazard ratio (aHR) and cumulative probability of pneumonia. The result after PSM indicated a lower hazard ratio for pneumonia in aspirin users (aHR = 0.890, 95% confidence interval = 0.837–0.945). Therefore, patients with CCVDs who took aspirin had a lower risk of developing pneumonia than those who did not. In conclusion, this population-based cohort study demonstrated that long-term low-dose aspirin use is associated with a slightly decreased risk of pneumonia in patients with CCVDs.


2016 ◽  
Vol 48 (2) ◽  
pp. 798-805 ◽  
Author(s):  
Young-Il Kim ◽  
So Young Kim ◽  
Ji Hyun Kim ◽  
Jun Ho Lee ◽  
Young-Woo Kim ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-27 ◽  
Author(s):  
Francis K.L. Chan ◽  
En-Ling Leung Ki ◽  
Yee Kit Tse ◽  
Kim WL Au ◽  
Jessica Ching ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0147635 ◽  
Author(s):  
Sadanori Okada ◽  
Takeshi Morimoto ◽  
Hisao Ogawa ◽  
Mio Sakuma ◽  
Hirofumi Soejima ◽  
...  

2009 ◽  
Vol 136 (5) ◽  
pp. A-609
Author(s):  
Francis K.L. Chan ◽  
Jessica Ching ◽  
Bing Yee Suen ◽  
Justin Wu ◽  
Vincent W. Wong ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Ana Carolina Lupepsa ◽  
Paula Vargas-Sanchez ◽  
Marcella Goetz Moro ◽  
Leomar Emanuel Almeida Mecca ◽  
Marcela Claudino ◽  
...  

Abstract Background Several drugs are capable of promoting changes in bone metabolism. The aim of this study was to evaluate the effect of long-term low-dose aspirin (LDA) therapy on implant osseointegration. Methods Male Wistar rats were divided into 4 groups (n = 8/group) according to oral gavage solution received prior (42 days) to the implant surgery on the tibia. The control group was treated with saline solution for 7 (CG-7) and 28 (CG-28) days. The use of low-dose aspirin was performed in AG groups (6.75 mg/kg of aspirin) for 7 (AG-7) and 28 (AG-28) days. After experimental periods, histomorphometric evaluation of bone-to-implant contact (BIC) and the bone area between threads (BABT) was performed. Results Reduced BIC values were detected in AG-7 (62.8% ± 17.1) group compared to AG-28 (91.9% ± 5.4), CG-7 (82.7% ± 15.2), and CG-28 (89.9% ± 9.7). BABT evaluation revealed lower values in AG-7 (70.9% ± 15.2) compared to AG-28 (95.4% ± 3.7) and CG-28 (87.1% ± 10.2) groups. Conclusions The treatment with low doses of aspirin promoted a discrete inhibitory effect in the early stages (7 days) of repair after implant placement, specifically in the bone deposition. However, these effects were not detected in the late stages (28 days), considering BIC and BABT parameters.


Sign in / Sign up

Export Citation Format

Share Document